drugset

drugset / Trial / NCT01315327

Omega-3 Fatty Acids in Tourette's Disorder

NCT01315327 ↗

Completed 33 enrolled NYU Langone Health Tourette Association of America · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.

Timeline

Start: 2003-05
Primary completion: 2006-02
Completion: 2012-05

Publications

Results Gabbay V, Babb JS, Klein RG, Panzer AM, Katz Y, Alonso CM, Petkova E, Wang J, Coffey BJ. A double-blind, placebo-controlled trial of omega-3 fatty acids in Tourette's disorder. Pediatrics. 2012 Jun;129(6):e1493-500. doi: 10.1542/peds.2011-3384. Epub 2012 May 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Omega-3 fatty acids	Unknown	6000 mg	—

Indications